Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05313321 · ClinicalTrials.gov registry record
Survival of the Insignia Stem in Total Hip Arthroplasty
A clinical trial of Primary Total Hip Arthroplasty, sponsored by University of Utah.
- Active
- Registry status
- 100
- Enrollment target
- 1
- Study location
NCT05313321: Active study of Primary Total Hip Arthroplasty, sponsored by University of Utah.
NCT05313321 is a study of Primary Total Hip Arthroplasty that is active but no longer recruiting, run by University of Utah. The registered enrollment target is 100 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05313321, a study of Primary Total Hip Arthroplasty, is active but no longer recruiting, sponsored by University of Utah.
- ACTIVE NOT RECRUITING
- Registry status
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
The investigators primary objective of this study is to evaluate radiographic fit and fill of the Insignia stem and identify risk factors for aseptic failure. The investigators hypotheses being tested is: the newly designed Insignia stem demonstrates acceptable radiographic fit and fill by reviewing radiolucent lines \<2mm.
Primary Outcome
Reviewing radiographic radiolucent lines \<2mm
Conditions Studied
Interventions
- DEVICE Primary total hip arthroplasty receiving the Insignia Stem
Study Locations (1)
Utah
- University of Utah Orthopaedic Center - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2022-03-17 |
| Est. Completion | 2028-03 |
What the registry record for NCT05313321 still lists
NCT05313321 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Primary Total Hip Arthroplasty appearing as the primary indexed condition, and to 1 intervention - of which Primary total hip arthroplasty receiving the Insignia Stem is the first listed.
NCT05313321 reports a single indexed study location in Utah.
Frequently Asked Questions
What is clinical trial NCT05313321 about?
NCT05313321 is a clinical study titled "Survival of the Insignia Stem in Total Hip Arthroplasty". The investigators primary objective of this study is to evaluate radiographic fit and fill of the Insignia stem and identify risk factors for aseptic failure. The investigators hypotheses being tested is: the newly designed Insignia stem demonstrates acceptable radiographic fit and fill by reviewing...
What is the current status of trial NCT05313321?
This trial is currently active not recruiting. The enrollment target is 100 participants. The study started on 2022-03-17. Estimated completion is 2028-03.
What conditions does trial NCT05313321 study?
This clinical trial studies the following conditions: Primary Total Hip Arthroplasty.
What interventions are being tested in trial NCT05313321?
The interventions under investigation include: Primary total hip arthroplasty receiving the Insignia Stem (DEVICE).
Who is sponsoring clinical trial NCT05313321?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05313321 being conducted?
This trial has 1 study location across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Primary Total Hip Arthroplasty
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI